Benefits of statins in chronic obstructive pulmonary disease patients with pulmonary hypertension: A meta-analysis

Chronic obstructive pulmonary disease (COPD) with its comorbidities is one of the five major causes of death worldwide [1]. Pulmonary hypertension (PH) is a serious condition classified into five groups based on its pathogenesis, with Group 3 due to lung diseases and/or hypoxia [2].